Twelve months of heavy resistance training-;exercise that makes muscles work against a force-;around retirement preserves vital leg strength years later, show the follow up results of a clinical trial, published online in the open access journal BMJ Open Sport & Exercise Medicine.
Otsuka snaps up Jnana with its phenylketonuria drug for $800m
Otsuka will gain Jnana’s lead candidate JNT-517 for treating phenylketonuria (PKU), along with its drug discovery RAPID chemoproteomics platform. Image Credit: Ratana21 / Shutterstock. Otsuka
August 1, 2024